Vitality Boost combines CJC-1295, Epitalon and GHK-Cu for anti-aging, skin health, collagen synthesis, hair growth and cellular longevity
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
As discussed earlier in this chapter, there is also interest in combination interventions that involve the administration of other therapeutics, including anti-tau therapies, to patients alongside amyloid-lowering therapies (Cummings et al., 2024)
For some people, 1 mg supports weight loss, especially when combined with diet and exercise
Liraglutide, semaglutide and dulaglutide have demonstrated cardiovascular benefits, and Wegovy recently added to this evidence base: in the SELECT trial, patients on Wegovy had a 20% lower incidence of heart attack, stroke or death from heart disease compared to those on a placebo